Literature DB >> 9317016

Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.

R Blackstock1, J W Murphy.   

Abstract

Two isolates of Cryptococcus neoformans were identified as being widely divergent in pathogenic potential after intratracheal infection of mice. These isolates differed in their ability to upregulate capsule synthesis when grown under tissue culture conditions, and this property correlated with virulence. We postulated that differential capsule synthesis may cause differential stimulation of macrophages to produce products such as complement components. To test this hypothesis, heat-killed yeast cells were incubated with normal mouse peritoneal cells (PC) before the level of C3 secreted was determined. Cryptococcal stimulants were grown on mycological agar, which does not promote capsule synthesis, or in RPMI 1640 at 37 degrees C in an atmosphere of 5% CO2, which stimulates capsule synthesis, to determine the role that the capsule plays in the induction of C3 secretion. C3 levels were elevated in cultures containing cryptococci grown in RPMI 1640 at 37 degrees C in an atmosphere of 5% CO2, and the level of C3 detected was correlated with the amount of capsule expressed by the yeast cell stimulant. Nonencapsulated mutants of C. neoformans did not stimulate C3 secretion. Purified capsular polysaccharide (glucuronoxylomannan [GXM]) also stimulated the PC to secrete C3. Two signals were required before GXM stimulated C3 secretion. The second signal was identified as endotoxin present in small amounts (0.06 ng per ml) in tissue medium. Endotoxin may provide a priming stimulus for PC to express receptors or other cytokines needed for effective stimulation of C3. These experiments show that enhancement of C3 secretion by C. neoformans is due to GXM and is correlated with the virulence of the cryptococcal isolate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317016      PMCID: PMC175592          DOI: 10.1128/iai.65.10.4114-4121.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Agglutinin from Limulus polyphemus. Purification with formalinized horse erythrocytes as the affinity adsorbent.

Authors:  T P Nowak; S H Barondes
Journal:  Biochim Biophys Acta       Date:  1975-05-30

3.  Development of DNA probes for early diagnosis and epidemiological study of cryptococcosis in AIDS patients.

Authors:  I Polacheck; G Lebens; J B Hicks
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

4.  Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis.

Authors:  B Wong; J R Perfect; S Beggs; K A Wright
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Effect of lipopolysaccharide on C3 and C5 production by human lung cells.

Authors:  B L Rothman; M Merrow; A Despins; T Kennedy; D L Kreutzer
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

7.  Modulation of C2 and C3 gene expression of human peripheral blood monocytes by interleukin 1 beta, interferon gamma, tumor necrosis factor alpha and lipopolysaccharide.

Authors:  H Shimizu; T Sakano; A Fujie; S Nishimura; K Ueda
Journal:  Experientia       Date:  1992-12-01

8.  Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans.

Authors:  J L Curtis; G B Huffnagle; G H Chen; M L Warnock; M R Gyetko; R A McDonald; P J Scott; G B Toews
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

9.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

10.  Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.

Authors:  T R Kozel; M A Wilson; J W Murphy
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more
  7 in total

1.  Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.

Authors:  Rebecca Blackstock
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

2.  Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors.

Authors:  R Blackstock; K L Buchanan; R Cherniak; T G Mitchell; B Wong; A Bartiss; L Jackson; J W Murphy
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response.

Authors:  T McGaha; J W Murphy
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.

Authors:  Cheryl D Chun; Jessica C S Brown; Hiten D Madhani
Journal:  Cell Host Microbe       Date:  2011-03-17       Impact factor: 21.023

5.  Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates.

Authors:  R Blackstock; K L Buchanan; A M Adesina; J W Murphy
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).

Authors:  Oscar Zaragoza; Bettina C Fries; Arturo Casadevall
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 7.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.